IHT Wealth Management LLC Invests $227,000 in Sanofi (NASDAQ:SNY)

IHT Wealth Management LLC bought a new position in Sanofi (NASDAQ:SNY) during the 3rd quarter, Holdings Channel reports. The fund bought 3,945 shares of the company’s stock, valued at approximately $227,000.

Several other large investors have also recently made changes to their positions in the company. Iron Triangle Partners LP bought a new stake in shares of Sanofi in the third quarter worth about $15,084,000. Janus Henderson Group PLC increased its holdings in shares of Sanofi by 11.7% in the third quarter. Janus Henderson Group PLC now owns 881,682 shares of the company’s stock worth $50,817,000 after purchasing an additional 92,015 shares during the last quarter. HighTower Advisors LLC increased its holdings in shares of Sanofi by 1.0% in the third quarter. HighTower Advisors LLC now owns 88,100 shares of the company’s stock worth $5,081,000 after purchasing an additional 848 shares during the last quarter. Hilltop Holdings Inc. increased its holdings in shares of Sanofi by 47.9% in the third quarter. Hilltop Holdings Inc. now owns 10,224 shares of the company’s stock worth $589,000 after purchasing an additional 3,313 shares during the last quarter. Finally, Cinctive Capital Management LP increased its holdings in shares of Sanofi by 106.6% in the third quarter. Cinctive Capital Management LP now owns 155,109 shares of the company’s stock worth $8,939,000 after purchasing an additional 80,033 shares during the last quarter. 10.04% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on SNY shares. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research report on Friday, December 6th. Citigroup upgraded Sanofi to a “strong-buy” rating in a research report on Tuesday, September 17th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $57.50.

Sanofi Trading Down 0.7 %

SNY opened at $48.08 on Wednesday. The firm has a market cap of $122.02 billion, a P/E ratio of 24.53, a P/E/G ratio of 1.23 and a beta of 0.58. Sanofi has a 12 month low of $45.22 and a 12 month high of $58.97. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The stock has a 50-day moving average of $51.71 and a 200 day moving average of $52.12.

Sanofi (NASDAQ:SNY) last announced its earnings results on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The business had revenue of $13.44 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same quarter in the previous year, the business earned $2.55 earnings per share. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. As a group, research analysts forecast that Sanofi will post 4.27 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.